Comparative efficacy of tildipirosin and cefquinome for the treatment of undifferentiated bovine respiratory disease among replacement dairy cattle raised in Chiang Mai Province, Thailand https://doi.org/10.12982/VIS.2024.049
Article Sidebar
Main Article Content
Abstract
The objective of this study was to compare the efficacy of tildipirosin and cefquinome for treatment of undifferentiated bovine respiratory disease (BRD) among replacement dairy cattle (calves and heifers) inhabiting dairy farms located in Chiang Mai, Thailand. A total of 52 animals with undifferentiated BRD were enrolled in the study and randomly selected for placement in antibiotic treatment groups. Out of 52 animals, 36 animals were treated with tildipirosin and were subcutaneously given 4 mg/kg body weight once, while 16 animals were treated with cefquinome and were intramuscularly given 1 mg/kg body weight once daily over a period of three days. Physical examinations and clinical attitude scoring (CAS) were performed on Day 1, Day 2, and Day 3 of the treatment periods. The cure rates of the tildipirosin and cefquinome treatment groups were not significantly different (p > 0.05) at percentages of 75.0% (27/36) and 87.5% (14/16), respectively. However, for comparisons within groups, rectal temperatures, respiratory rates, and CAS values were observed to have significantly decreased after treatment with both tildipirosin and cefquinome on Day 3 (p < 0.05). Furthermore, rumen contraction rate was also significantly increased after treatments with both antibiotics (p < 0.05). The degree of efficacy of both antibiotics was similar when the clinical signs and clinical cure rates at the post-treatment point between the two groups were compared. Therefore, the outcomes of this study expand the options for the antibiotic-based treatment of undifferentiated BRD among dairy calves and heifers being raised in this area.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publishing an article with open access in Veterinary Integrative Sciences leaves the copyright with the author. The article is published under the Creative Commons Attribution License 4.0 (CC-BY 4.0), which allows users to read, copy, distribute and make derivative works from the material, as long as the author of the original work is cited.
References
Ball, J.J., Kegley, E.B., Sarchet, J., Powell, J.G., 2019. Comparison of treatment protocols for bovine respiratory disease in high-risk, newly received beef calves. Appl. Anim. Sci.35(3), 278–283.
Bartram, D.J., Moyaert, H., Vanimisetti, B.H., Ramage, C.P., Reddick, D., Stegemann,M. R., 2016. Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental Mycoplasma bovis infection in calves. Vet. Med. Sci.
(3), 170–178.
Booker, C.W., Lubbers, B.V., 2020. Bovine respiratory disease treatment failure: impact and potential causes. Vet. Clin. North Am. Food Anim. 36(2), 487–496.
Confer, A.W., Snider, T.A., Taylor, J.D., Montelongo, M., Sorensen, N.J., 2016. Clinical disease and lung lesions in calves experimentally inoculated with Histophilus somni five days after metaphylactic administration of tildipirosin or tulathromycin. Am. J.Vet. Res. 77(4), 358–366.
Cummings, D.B., Meyer, N.F., Step, D.L., 2022. Bovine respiratory disease considerations in young dairy calves. Vet. Clin. North Am. Food Anim. 38(1), 93–105.
CVMP, 2003. Cefquinome (extension to horses). Summary report (3). EMEA/MRL/883/03-final. European Agency for the Evaluation of Medicinal Products, London,United Kingdom.
DeDonder, K.D., Harhay, D.M., Apley, M.D., Lubbers, B.V., Clawson, M.L., Schuller, G.,Harhay, G.P., White, B.J., Larson, R.L., Capik, S.F., Riviere, J.E., Kalbfleisch, T., Tessman, R.K., 2016. Observations on macrolide resistance and susceptibility testing performance in field isolates collected from clinical bovine respiratory disease cases. Vet. Microbiol. 192, 186–193.
de Jong, A., Thomas, V., Simjee, S., Moyaert, H., El Garch, F., Maher, K., Morrissey, I.,Butty, P., Klein, U., Marion, H., Rigaut, D., Vallé, M., 2014. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study. Vet. Microbiol. 172(1-2), 202–215.
Dubrovsky, S.A., Van Eenennaam, A.L., Karle, B.M., Rossitto, P.V., Lehenbauer, T.W.,Aly, S.S., 2019. Bovine respiratory disease (BRD) cause-specific and overall mortality in preweaned calves on California dairies: the BRD 10K study. J. Dairy.Sci. 102(8), 7320–7328.
Fowler, J., Stieger-Vanegas, S.M., Vanegas, J.A., Bobe, G., Poulsen, K.P., 2017. Comparison of thoracic radiography and computed tomography in calves with naturally occurring respiratory disease. Front. Vet. Sci. 4, 101.
Griffin, D., 1997. Economic impact associated with respiratory disease in beef cattle. Vet.Clin. North Am. Food Anim. Pract. 13(3), 367–377.
Hoar, B.R., Jelinski, M.D., Ribble, C.S., Janzen, E.D., Johnson, J.C., 1998. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Can. Vet.
J. 39(3), 161–166.
Khamesipour, F., Momtaz, H., Azhdary Mamoreh, M., 2014. Occurrence of virulence factors and antimicrobial resistance in Pasteurella multocida strains isolated from slaughter cattle in Iran. Front. Microbiol. 5, 536.
Kumar, P., Jain, V.K., Kumar, A., Sindhu, N., Kumar, T., Charaya, G., Surbhi, Kumar, S.,Agnihotri, D., Sridhar., 2015. Clinical and hemato-biochemical studies on fever of unknown origin in buffaloes. Vet. World. 8(10), 1225–1229.
Martin, M., Kleinhenz, M., Kleinhenz, K., Reppert, E., Blasi, D., Parks, T., Baysinger, A.,Hutcheson, J., Coetzee, J., 2020. Comparison of the effect of tildipirosin administered alone or in combination with transdermal flunixin on the performance,
health, activity, and well-being of transported feedlot calves on arrival at the feedlot.Transl. Anim. Sci. 4(1), 452–459.
Maunsell, F.P., Woolums, A.R., Francoz, D., Rosenbusch, R.F., Step, D.L., Wilson, D.J.,Janzen, E.D., 2011. Mycoplasma bovis infections in cattle. J. Vet. Intern. Med.25(4), 772–783.
McConnel, C.S., Lombard, J.E., Wagner, B.A., Garry, F.B., 2008. Evaluation of factors associated with increased dairy cow mortality on United States dairy operations. J.Dairy Sci. 91(4), 1423–1432. Menge, M., Rose, M., Bohland, C., Zschiesche, E., Kilp,
S., Metz, W., Allan, M., Röpke, R.,Nürnberger, M., 2012. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). J. Vet. Pharmacol.Ther. 35(6), 550–559.
Padalino, B., Cirone, F., Zappaterra, M., Tullio, D., Ficco, G., Giustino, A., Ndiana, L.A.,Pratelli, A., 2021. Factors affecting the development of bovine respiratory disease: a cross-sectional study in beef steers shipped from France to Italy. Front. Vet. Sci. 8,627894.
Perez-Casal, J., 2020. Pathogenesis and virulence of mycoplasma bovis. Vet. Clin. North Am.Food Anim. 36(2), 269–278.
Saipinta, D., Panyamongkol, T., Chuammitri, P., Suriyasathaporn, W., 2022. Reduction in mortality of calves with bovine respiratory disease in detection with Influenza C and D Virus. Animals (Basel). 12(23), 3252.
Singhla, T., Tankaew, P., Sthitmatee, N., 2020. Validation of a Novel ELISA for the diagnosis of hemorrhagic septicemia in dairy cattle from Thailand using a bayesian approach.Vet Sci. 7(4), 163.